Senores Pharmaceuticals Limited's Board of Directors, at a meeting held on Monday, June 2, 2025, appointed Sharp & Tannan Associates, Chartered Accountants (Firm Registration No. 109983W), as the Internal Auditor of the Company.
This appointment is for the Financial Year 2025-26, based on the recommendation of the Audit Committee.
Sharp & Tannan Associates, established in 1934, has its head office in Mumbai and branches across India, including Ahmedabad and Baroda in Gujarat.
The firm currently has nine partners and possesses over six decades of experience in internal audit, assurance, and other consulting works.
They are proponents of risk-based auditing, focusing on a value-added approach to business processes and adhering to the COSO 1992 framework.
The firm also emphasizes early adoption of RPAs/Robotics automations in internal audit and consulting assignments for improved efficiency.
The Board meeting commenced at 12:15 P.M. (IST) and concluded at 01:40 P.M. (IST) on June 2, 2025.